Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Mar;63(3):431-4.
doi: 10.1001/archneur.63.3.431.

Association of apolipoprotein E genotype and Alzheimer disease in African Americans

Jill R Murrell  1 , Brandon Price, Kathleen A Lane, Olusegun Baiyewu, Oye Gureje, Adesola Ogunniyi, Frederick W Unverzagt, Valerie Smith-Gamble, Sujuan Gao, Hugh C Hendrie, Kathleen S Hall
Affiliations
Comparative Study

Association of apolipoprotein E genotype and Alzheimer disease in African Americans

Jill R Murrell et al. Arch Neurol. 2006 Mar.

Abstract

Background: Alzheimer disease (AD) is the most frequent cause of dementia. Even though the incidence of AD in the African American population is similar to or higher than that in persons of European descent, AD in African Americans is understudied. Identification of genetic risk factors in African Americans is essential for understanding the etiology of AD.

Objective: To determine the effect of apolipoprotein E (APOE) genotype on the risk of AD in elderly African Americans.

Design: Population-based longitudinal study of AD.

Setting: Indianapolis, Ind.

Participants: African Americans 65 years and older.

Main outcome measures: APOE genotype and diagnosis of AD.

Results: The APOE genotype was determined in 1822 samples. Of these, 690 were clinically evaluated: 318 were normal, and 162 had a diagnosis of AD. The presence of APOE epsilon4 was significantly associated with increased risk of AD (epsilon3/epsilon4: OR, 2.32; 95% confidence interval [CI], 1.41-3.82; and epsilon4/epsilon4: OR, 7.19; 95% CI, 3.00-17.29, compared with the epsilon3/epsilon3 genotype). There was also a significant protective effect with APOE epsilon2 (epsilon2/epsilon2 and epsilon2/epsilon3: OR, 0.42; 95% CI, 0.20-0.89).

Conclusions: These findings are in marked contrast to the lack of association between APOE and AD in the Ibadan, Nigeria, sample of this project. These results suggest that other genetic factors and different environmental influences may play a role in the risk for AD in individuals of African ancestry.

PubMed Disclaimer

References

    1. Ernst RL, Hay JW. The US economic and social costs of Alzheimer’s disease revisited. Am J Public Health. 1994;84:1261–1264. - PMC - PubMed
    1. Prince M 10/66 Dementia Research Group. Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry. 2004;19:170–177. - PubMed
    1. Evans DA, Bennett DA, Wilson RS, et al. Incidence of Alzheimer disease in a biracial urban community. Arch Neurol. 2003;60:185–189. - PubMed
    1. Fillenbaum GG, Heyman A, Huber MS, et al. The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol. 1998;51:587–595. - PubMed
    1. Green RC, Cupples LA, Go R, et al. MIRAGE Study Group. Risk of dementia among white and African American relatives of patients with Alzheimer disease. JAMA. 2002;287:329–336. - PubMed

Publication types

Substances